These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

154 related articles for article (PubMed ID: 24771299)

  • 1. A pilot study: dose adaptation of capecitabine using mobile phone toxicity monitoring - supporting patients in their homes.
    Weaver A; Love SB; Larsen M; Shanyinde M; Waters R; Grainger L; Shearwood V; Brooks C; Gibson O; Young AM; Tarassenko L
    Support Care Cancer; 2014 Oct; 22(10):2677-85. PubMed ID: 24771299
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Safety profile and activity of lower capecitabine dose in patients with metastatic breast cancer.
    Rossi D; Alessandroni P; Catalano V; Giordani P; Fedeli SL; Fedeli A; Baldelli AM; Casadei V; Ceccolini M; Catalano G
    Clin Breast Cancer; 2007 Dec; 7(11):857-60. PubMed ID: 18269775
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Phase I study of a novel capecitabine schedule based on the Norton-Simon mathematical model in patients with metastatic breast cancer.
    Traina TA; Theodoulou M; Feigin K; Patil S; Tan KL; Edwards C; Dugan U; Norton L; Hudis C
    J Clin Oncol; 2008 Apr; 26(11):1797-802. PubMed ID: 18398145
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical features of oral chemotherapy: results of a longitudinal prospective study of breast and colorectal cancer patients receiving capecitabine in the UK.
    Brearley SG; Craven O; Saunders M; Swindell R; Molassiotis A
    Eur J Cancer Care (Engl); 2010 Jul; 19(4):425-33. PubMed ID: 19708942
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Oral capecitabine (Xeloda) in cancer treatment.
    Doyle DP; Engelking C
    Nurse Pract; 2007 Feb; 32(2):18-21. PubMed ID: 17264789
    [No Abstract]   [Full Text] [Related]  

  • 6. Lower dose capecitabine has a more favorable therapeutic index in metastatic breast cancer: retrospective analysis of patients treated at M. D. Anderson Cancer Center and a review of capecitabine toxicity in the literature.
    Hennessy BT; Gauthier AM; Michaud LB; Hortobagyi G; Valero V
    Ann Oncol; 2005 Aug; 16(8):1289-96. PubMed ID: 15890665
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Cardiotoxicity of fluoropyrimidines in different schedules of administration: a prospective study.
    Kosmas C; Kallistratos MS; Kopterides P; Syrios J; Skopelitis H; Mylonakis N; Karabelis A; Tsavaris N
    J Cancer Res Clin Oncol; 2008 Jan; 134(1):75-82. PubMed ID: 17636329
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Is a nurse-led telephone intervention a viable alternative to nurse-led home care and standard care for patients receiving oral capecitabine? Results from a large prospective audit in patients with colorectal cancer.
    Craven O; Hughes CA; Burton A; Saunders MP; Molassiotis A
    Eur J Cancer Care (Engl); 2013 May; 22(3):413-9. PubMed ID: 23527965
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Pharmacokinetics and exposure-effect relationships of capecitabine in elderly patients with breast or colorectal cancer.
    Daher Abdi Z; Lavau-Denes S; Prémaud A; Urien S; Sauvage FL; Martin J; Leobon S; Marquet P; Tubiana-Mathieu N; Rousseau A
    Cancer Chemother Pharmacol; 2014 Jun; 73(6):1285-93. PubMed ID: 24801171
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Capecitabine non-adherence: exploration of magnitude, nature and contributing factors.
    Bhattacharya D; Easthall C; Willoughby KA; Small M; Watson S
    J Oncol Pharm Pract; 2012 Sep; 18(3):333-42. PubMed ID: 22298660
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mobile health for drug dose optimisation.
    Larsen ME; Farmer A; Weaver A; Young A; Tarassenko L
    Annu Int Conf IEEE Eng Med Biol Soc; 2011; 2011():1540-3. PubMed ID: 22254614
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Phase I study of postoperative radiotherapy combined with capecitabine for gastric cancer.
    Wang X; Jin J; Li YX; Ren H; Fang H; Wang SL; Liu YP; Wang WH; Yu ZH; Song YW; Liu XF
    World J Gastroenterol; 2014 Jan; 20(4):1067-73. PubMed ID: 24574780
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Study on adherence to capecitabine among patients with colorectal cancer and metastatic breast cancer.
    Figueiredo Junior AG; Forones NM
    Arq Gastroenterol; 2014; 51(3):186-91. PubMed ID: 25296077
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Effectiveness of a home care nursing program in the symptom management of patients with colorectal and breast cancer receiving oral chemotherapy: a randomized, controlled trial.
    Molassiotis A; Brearley S; Saunders M; Craven O; Wardley A; Farrell C; Swindell R; Todd C; Luker K
    J Clin Oncol; 2009 Dec; 27(36):6191-8. PubMed ID: 19917849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A phase I trial of preoperative radiotherapy and capecitabine for locally advanced, potentially resectable rectal cancer.
    Ngan SY; Michael M; Mackay J; McKendrick J; Leong T; Lim Joon D; Zalcberg JR
    Br J Cancer; 2004 Sep; 91(6):1019-24. PubMed ID: 15305186
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relationship between single nucleotide polymorphisms and haplotypes in DPYD and toxicity and efficacy of capecitabine in advanced colorectal cancer.
    Deenen MJ; Tol J; Burylo AM; Doodeman VD; de Boer A; Vincent A; Guchelaar HJ; Smits PH; Beijnen JH; Punt CJ; Schellens JH; Cats A
    Clin Cancer Res; 2011 May; 17(10):3455-68. PubMed ID: 21498394
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Application of mobile phone technology for managing chemotherapy-associated side-effects.
    Weaver A; Young AM; Rowntree J; Townsend N; Pearson S; Smith J; Gibson O; Cobern W; Larsen M; Tarassenko L
    Ann Oncol; 2007 Nov; 18(11):1887-92. PubMed ID: 17921245
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Fixed-dose capecitabine is feasible: results from a pharmacokinetic and pharmacogenetic study in metastatic breast cancer.
    Rudek MA; Connolly RM; Hoskins JM; Garrett-Mayer E; Jeter SC; Armstrong DK; Fetting JH; Stearns V; Wright LA; Zhao M; Watkins SP; McLeod HL; Davidson NE; Wolff AC
    Breast Cancer Res Treat; 2013 May; 139(1):135-43. PubMed ID: 23588952
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Dose-finding and pharmacokinetic study of an all-oral combination regimen of oral vinorelbine and capecitabine for patients with metastatic breast cancer.
    Nolè F; Catania C; Sanna G; Imadalou K; Munzone E; Adamoli L; Longerey B; Blanchot G; Goldhirsch A
    Ann Oncol; 2006 Feb; 17(2):322-9. PubMed ID: 16303864
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Single-agent capecitabine in patients with metastatic colorectal cancer refractory to 5-fluorouracil/leucovorin chemotherapy.
    Lee JJ; Kim TM; Yu SJ; Kim DW; Joh YH; Oh DY; Kwon JH; Kim TY; Heo DS; Bang YJ; Kim NK
    Jpn J Clin Oncol; 2004 Jul; 34(7):400-4. PubMed ID: 15342667
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.